These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2033 related items for PubMed ID: 14737169

  • 1. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
    Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG.
    Nature; 2004 Jan 22; 427(6972):355-60. PubMed ID: 14737169
    [Abstract] [Full Text] [Related]

  • 2. Finding a way out: lymphocyte egress from lymphoid organs.
    Schwab SR, Cyster JG.
    Nat Immunol; 2007 Dec 22; 8(12):1295-301. PubMed ID: 18026082
    [Abstract] [Full Text] [Related]

  • 3. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K, Matsuyuki H, Maeda Y, Sugahara K.
    Cell Mol Immunol; 2006 Feb 22; 3(1):11-9. PubMed ID: 16549044
    [Abstract] [Full Text] [Related]

  • 4. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y, Seki N, Sato N, Sugahara K, Chiba K.
    Int Immunol; 2010 Jun 22; 22(6):515-25. PubMed ID: 20497959
    [Abstract] [Full Text] [Related]

  • 5. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.
    Shiow LR, Rosen DB, Brdicková N, Xu Y, An J, Lanier LL, Cyster JG, Matloubian M.
    Nature; 2006 Mar 23; 440(7083):540-4. PubMed ID: 16525420
    [Abstract] [Full Text] [Related]

  • 6. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
    Morris MA, Gibb DR, Picard F, Brinkmann V, Straume M, Ley K.
    Eur J Immunol; 2005 Dec 23; 35(12):3570-80. PubMed ID: 16285007
    [Abstract] [Full Text] [Related]

  • 7. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
    Hofmann M, Brinkmann V, Zerwes HG.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1902-10. PubMed ID: 17161343
    [Abstract] [Full Text] [Related]

  • 8. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K.
    Pharmacol Ther; 2005 Dec 20; 108(3):308-19. PubMed ID: 15951022
    [Abstract] [Full Text] [Related]

  • 9. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
    Matsuyuki H, Maeda Y, Yano K, Sugahara K, Chiba K, Kohno T, Igarashi Y.
    Cell Mol Immunol; 2006 Dec 20; 3(6):429-37. PubMed ID: 17257496
    [Abstract] [Full Text] [Related]

  • 10. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.
    Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, Rosenbach M, Hale J, Lynch CL, Rupprecht K, Parsons W, Rosen H.
    Science; 2002 Apr 12; 296(5566):346-9. PubMed ID: 11923495
    [Abstract] [Full Text] [Related]

  • 11. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
    Sensken SC, Bode C, Gräler MH.
    J Pharmacol Exp Ther; 2009 Mar 12; 328(3):963-9. PubMed ID: 19074680
    [Abstract] [Full Text] [Related]

  • 12. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors.
    Gräler MH, Goetzl EJ.
    FASEB J; 2004 Mar 12; 18(3):551-3. PubMed ID: 14715694
    [Abstract] [Full Text] [Related]

  • 13. Kruppel-like factor 2 regulates thymocyte and T-cell migration.
    Carlson CM, Endrizzi BT, Wu J, Ding X, Weinreich MA, Walsh ER, Wani MA, Lingrel JB, Hogquist KA, Jameson SC.
    Nature; 2006 Jul 20; 442(7100):299-302. PubMed ID: 16855590
    [Abstract] [Full Text] [Related]

  • 14. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.
    Cyster JG.
    Annu Rev Immunol; 2005 Jul 20; 23():127-59. PubMed ID: 15771568
    [Abstract] [Full Text] [Related]

  • 15. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.
    Forrest M, Sun SY, Hajdu R, Bergstrom J, Card D, Doherty G, Hale J, Keohane C, Meyers C, Milligan J, Mills S, Nomura N, Rosen H, Rosenbach M, Shei GJ, Singer II, Tian M, West S, White V, Xie J, Proia RL, Mandala S.
    J Pharmacol Exp Ther; 2004 May 20; 309(2):758-68. PubMed ID: 14747617
    [Abstract] [Full Text] [Related]

  • 16. The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology.
    von Wenckstern H, Zimmermann K, Kleuser B.
    Arch Immunol Ther Exp (Warsz); 2006 May 20; 54(4):239-51. PubMed ID: 16830220
    [Abstract] [Full Text] [Related]

  • 17. CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors.
    Alfonso C, McHeyzer-Williams MG, Rosen H.
    Eur J Immunol; 2006 Jan 20; 36(1):149-59. PubMed ID: 16342326
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement.
    Vora KA, Nichols E, Porter G, Cui Y, Keohane CA, Hajdu R, Hale J, Neway W, Zaller D, Mandala S.
    J Leukoc Biol; 2005 Aug 20; 78(2):471-80. PubMed ID: 15894589
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 102.